The HP1α-V3 to STET ratio was significantly higher in primary carcinomas both from patients without metastasis (1.97-fold, P < 0.0001) and with metastasis (1.81-fold, P < 0.0001) relative to normal breast (Fig. 6e). Here, CBX5 is linked to carcinoma.